Cosmos Week
Galaxy Mergers Aren't Always Obvious
BiologyEnglish editionScience journalismJournalistic coverage

Galaxy Mergers Aren't Always Obvious

Mergers are a part of a galaxy's life in this Universe. Though clear signs of these mergers fade over hundreds of millions of years, evidence is still present, yet obscured, in.

Original source cited and editorially framed by Cosmos Week. Universe Today
Editorial signatureCosmos Week Editorial Desk
Published07 Jul 2026 16: 24 UTC
Updated2026-07-07
Coverage typeScience journalism
Evidence levelJournalistic coverage
Read time4 min read

Key points

  • Focus: Mergers are a part of a galaxy's life in this Universe
  • Detail: Science reporting: verify primary technical documentation
  • Editorial reading: science reporting; whenever possible, verify the cited primary source.
Full story

Mergers are a part of a galaxy's life in this Universe. Though clear signs of these mergers fade over hundreds of millions of years, evidence is still present, yet obscured, in the galaxies that experience them. The science-journalism coverage adds useful context, while the strongest evidential footing still comes from the underlying data, papers or institutional documentation.

That matters because biology becomes more informative when an observed effect begins to look like a mechanism rather than an isolated pattern. The gap between identifying a correlation in biological data and understanding the causal chain that produces it is routinely underestimated, and the history of biomedical research is populated with associations that collapsed when the mechanism was sought and not found. A result that comes with a proposed mechanism, even a partial one, is more useful than a purely descriptive finding because it generates testable predictions that can narrow the hypothesis space. The galaxy Centaurus A is about 11 million light years away and is the fifth brightest galaxy in the sky. Also called NGC 5128, it's a starburst galaxy, meaning its forming stars at a rapid rate.

Centaurus A is no exception, and new JWST observations have revealed evidence of a past merger. At first, two or more galaxies on a collision course interact gravitationally, and a first pass can form long streams of gas and stars called tidal tails or bridges.

All of this change can drive star-forming gas to greater density, triggering rapid star formation, and the result is a starburst galaxy like NGC 5128. In visible light images of NGC 5128, thick dust lanes obscure much of the galaxy's center.

That's what the JWST did with NGC 5128, capturing images that mark the space telescope's fourth year of observations. No single telescope tells the whole story,” said Shawn Domagal-Goldman, division director, Astrophysics, NASA Headquarters in Washington.

The broader interest lies in whether the reported effect points toward a real mechanism and not merely a reproducible but unexplained association. Biology has learned from decades of biomarker failures that correlation, even robust correlation, is not a substitute for mechanistic understanding. A pathway that can be traced from molecular interaction to cellular response to organismal phenotype provides a far stronger foundation for intervention than a statistical association discovered in a large dataset, however well the statistics are done.

The JWST does more than capture images. While the JWST can't provide answers to all of our questions about galaxies, their mergers, and their black holes, the powerful telescope can at least nudge those questions.

Because this item comes through Universe Today as science journalism, it should be treated as contextual reporting rather than primary evidence. Good science reporting can identify why a result matters, connect it to the wider literature and make technical work readable, but the decisive evidence remains in the original paper, dataset, mission release or technical record. That distinction is especially important when a story is later repeated by aggregators, because repetition increases visibility, not evidential strength.

The next step is to test whether the effect repeats across different methods, cell types, model organisms and experimental conditions. Reproducibility is the first test, but mechanistic dissection is the second, and a result that passes both has a substantially better chance of translating into something clinically or biotechnologically useful. The path from a laboratory finding to an applied outcome typically takes a decade or more, and most findings do not complete it; the current result sits at the beginning of that process.

Source